Global Zika Virus Therapeutics Market 2019-2023

Global Zika Virus Therapeutics Market 2019-2023

Global Zika Virus Therapeutics Market: About this market

Technavio’s Zika virus therapeutics market analysis considers the revenues based on products such as acetaminophen and other nonsteroidal anti-inflammatory drugs (NSAIDs). Our analysis also considers the sales of Zika virus therapeutics in North America, Asia, Europe, and ROW. In 2018, the acetaminophen segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as safety and efficacy will play a significant role in the acetaminophen segment to maintain its market position. , our global Zika virus therapeutics market report looks at factors such as the availability of serology kit for qualitative diagnosis of Zika virus infection, the high incidence rate of infection, and disease burden of Zika virus infection and associated comorbidities. However, the asymptomatic nature of the infection, lack of approved Zika virus therapeutics, and stringent regulatory guidelines may hamper the growth of the Zika virus therapeutics industry over the forecast period.

Global Zika virus therapeutics market: Overview

Rising disease burden of Zika virus infection and associated comorbidities

The incidences of Zika virus infection has been increasing at a significant rate over the last few years and is gradually reaching epidemic proportions across the globe. Zika virus infection can affect both fetuses and adults in the form of various clinical manifestations such as conjunctivitis, maculopapular pruritic rashes, arthralgia, congenital glaucoma, microcephaly, and optic neuropathy. Thus, the rising disease burden of Zika virus infection and associated comorbidities will fuel the expansion of the Zika virus therapeutics market at a CAGR of over 4% during the forecast period.

Novel approach for vaccine development

The Zika virus therapeutics market is witnessing the emergence of novel approaches for vaccine development. The use of ribonucleic acid as a vaccine is one of the novel approaches that have emerged in the market. The promising results of vaccines are further encouraging research organizations to invest in the R&D of the vaccines for human models. Thus, the emergence of novel approaches for vaccine development will fuel the growth of the market during the forecast period.

For the detailed list of factors that will drive the global Zika virus therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global Zika virus therapeutics market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Zika virus therapeutics companies, that include Aurobindo Pharma Ltd., Johnson & Johnson Services Inc., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Co. Ltd.



Also, the Zika virus therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global infectious disease treatment market
      • Table Segments of global infectious disease treatment market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Pipeline analysis
    • Table Some therapeutics in clinical trials for Zika virus infection
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Acetaminophen - Market size and forecast 2018-2023
      • Table Acetaminophen - Market size and forecast 2018-2023 ($ millions)
      • Table Acetaminophen - Year-over-year growth 2019-2023 (%)
    • Other NSAIDs - Market size and forecast 2018-2023
      • Table Other NSAIDs - Market size and forecast 2018-2023 ($ millions)
      • Table Other NSAIDs - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Increasing efforts by government and private organizations to facilitate vaccine development
    • Classification of Zika virus infection as public health emergency
    • Novel approach for vaccine development
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Aurobindo Pharma Ltd.
      • Table Aurobindo Pharma Ltd. - Vendor overview
      • Table Aurobindo Pharma Ltd. - Business segments
      • Table Aurobindo Pharma Ltd. - Organizational developments
      • Table Aurobindo Pharma Ltd. - Geographic focus
      • Table Aurobindo Pharma Ltd. - Key offerings
      • Table Aurobindo Pharma Ltd. - Key customers
    • Johnson & Johnson Services Inc.
      • Table Johnson & Johnson Services Inc. - Vendor overview
      • Table Johnson & Johnson Services Inc. - Business segments
      • Table Johnson & Johnson Services Inc. - Organizational developments
      • Table Johnson & Johnson Services Inc. - Geographic focus
      • Table Johnson & Johnson Services Inc. - Segment focus
      • Table Johnson & Johnson Services Inc. - Key offerings
      • Table Johnson & Johnson Services Inc. - Key customers
    • Perrigo Co. Plc
      • Table Perrigo Co. Plc - Vendor overview
      • Table Perrigo Co. Plc - Business segments
      • Table Perrigo Co. Plc - Organizational developments
      • Table Perrigo Co. Plc - Geographic focus
      • Table Perrigo Co. Plc - Segment focus
      • Table Perrigo Co. Plc - Key offerings
      • Table Perrigo Co. Plc - Key customers
    • Sun Pharmaceutical Industries Ltd.
      • Table Sun Pharmaceutical Industries Ltd. - Vendor overview
      • Table Sun Pharmaceutical Industries Ltd. - Business segments
      • Table Sun Pharmaceutical Industries Ltd. - Organizational developments
      • Table Sun Pharmaceutical Industries Ltd. - Geographic focus
      • Table Sun Pharmaceutical Industries Ltd. - Segment focus
      • Table Sun Pharmaceutical Industries Ltd. - Key offerings
      • Table Sun Pharmaceutical Industries Ltd. - Key customers
    • Takeda Pharmaceutical Co. Ltd.
      • Table Takeda Pharmaceutical Co. Ltd. - Vendor overview
      • Table Takeda Pharmaceutical Co. Ltd. - Business segments
      • Table Takeda Pharmaceutical Co. Ltd. - Organizational developments
      • Table Takeda Pharmaceutical Co. Ltd. - Geographic focus
      • Table Takeda Pharmaceutical Co. Ltd. - Key offerings
      • Table Takeda Pharmaceutical Co. Ltd. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook